Maravai LifeSciences Holdings, Inc. MRVI Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$6.38M+87.9% | -$63.02M-36.8% | -$45.06M+73.9% | -$69.84M-279% | -$52.85M-133% | ||
| $4.9M-13.9% | $5.93M+8.5% | $5.98M+18.5% | $5.96M+7.2% | $5.69M+19.0% | ||
| $6.74M-35.2% | $3.93M-62.8% | $9.06M-30.6% | $6.79M-50.7% | $10.4M-13.7% | ||
| $605K-95.1% | $41.71M+249% | $0-100% | $30.45M— | $12.44M— | ||
| $7.91M+178% | —— | -$5.12M+15.0% | -$501K+73.5% | -$10.16M+43.2% | ||
| -$33K+92.7% | -$3.09M-584% | -$1.35M-185% | -$3.11M-343% | -$449K+45.2% | ||
| $6.16M+970% | -$5.52M-345% | -$2.91M-20.1% | $1.78M-61.0% | -$708K+80.8% | ||
| -$5.34M-390% | -$13.51M-764% | $1.51M+243% | $5.54M— | $1.84M+108% | ||
| -$1.43M+36.1% | -$1.18M-40.1% | -$1.07M-143% | $2.86M— | -$2.24M-207% | ||
| -$203K+97.6% | -$1.89M-64.6% | -$2.06M-591% | -$6.19M-66.1% | -$8.49M-654% | ||
| -$541K-140% | —— | -$334K+55.2% | -$732K-275% | -$225K-0.9% | ||
| $6.47M-7.9% | $6.51M-5.7% | $7.21M+4.6% | $7.2M+4.8% | $7.03M+2.3% | ||
| $1.61M-26.6% | $2.29M+6.0% | $2.26M+7.4% | $2.23M+5.0% | $2.19M+4.2% | ||
| $8.67M+192% | -$22.77M— | -$15.15M-215% | -$10.27M-159% | -$9.39M-10.9% | ||
| $4.44M-1.4% | $2.11M-63.9% | $2.93M-65.9% | $3.61M-62.2% | $4.5M-20.5% | ||
| $0-100% | —— | —— | $362K— | $18.63M— | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| -$4.44M+80.8% | -$2.11M+57.1% | -$2.93M+67.3% | -$3.24M+47.7% | -$23.13M-445% | ||
| $51.36M+3,676% | $1.36M-99.4% | $1.36M0.0% | $1.36M0.0% | $1.36M0.0% | ||
| -$3.87M-9.2% | —— | —— | —— | -$3.54M— | ||
| -$55.23M-1,027% | -$1.82M+99.2% | -$8.25M-1,120% | -$1.53M— | -$4.9M-775% | ||
| $30K-58.9% | —— | -$8K— | -$111K— | $73K— | ||
| -$50.97M-36.5% | -$26.68M+89.6% | -$26.33M-628% | -$15.15M— | -$37.35M-181% | ||
| $6.15M-5.7% | $6.21M-58.9% | $6.13M-48.3% | $6.12M-48.4% | $6.52M-46.3% | ||
| $0-100% | $0-100% | -$26K-110% | -$674K-474% | $139K-29.4% | ||
| $6.47M-7.9% | $6.51M-5.7% | $7.21M+4.6% | $7.2M+4.8% | $7.03M+2.3% | ||
| $605K-95.1% | —— | —— | —— | $12.44M-70.1% | ||
| $4.9M-13.9% | $5.93M+8.5% | $5.98M+18.5% | $5.96M+7.2% | $5.69M+19.0% | ||
| -$203K+97.6% | -$1.89M-64.6% | -$2.06M-591% | -$6.19M-66.1% | -$8.49M-654% | ||
| —— | -$45.25K-18.3% | -$45.25K-18.3% | -$45.25K-18.3% | -$45.25K-18.3% | ||
| -$1.43M+36.1% | -$1.18M-40.1% | -$1.07M-143% | $2.86M— | -$2.24M-207% | ||
| $1.61M-26.6% | $2.29M+6.0% | $2.26M+7.4% | $2.23M+5.0% | $2.19M+4.2% | ||
| -$541K-140% | —— | -$334K+55.2% | -$732K-275% | -$225K-0.9% | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| —— | -$2.5K-102% | -$2.5K-102% | -$2.5K-102% | -$2.5K-102% | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| -$3.87M-9.2% | —— | —— | —— | -$3.54M-704% | ||
| $248K-82.7% | $2.75M+239% | —— | $288K-71.4% | $1.43M-54.6% | ||
| $0-100% | —— | —— | —— | $4.8M— | ||
| $0-100% | —— | —— | —— | $2.33M— | ||
| $0-100% | $0-100% | -$26K-110% | -$674K-474% | $139K-29.4% | ||
| $4.23M+130% | -$24.88M-21.5% | -$18.08M— | -$13.87M— | -$13.89M+1.7% | ||
| $4.23M+130% | -$24.88M-21.5% | -$18.08M— | -$13.87M— | -$13.89M+1.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Maravai LifeSciences Holdings, Inc. generate?
- Maravai LifeSciences Holdings, Inc. (MRVI) generated -$39.5M in operating cash flow over the trailing twelve months.
- What is Maravai LifeSciences Holdings, Inc.'s free cash flow?
- After $13.1M of capital expenditures, Maravai LifeSciences Holdings, Inc.'s free cash flow was -$52.6M over the trailing twelve months, down 283.3% year over year.
- Where does Maravai LifeSciences Holdings, Inc.'s cash flow data come from?
- Every line is extracted from Maravai LifeSciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
